Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs ProShares UltraPro Short QQQ ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while ProShares UltraPro Short QQQ ETF trades at $37.25 (market cap $2.13B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 14.5× ProShares UltraPro Short QQQ ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals.
| GEHC | SQQQ | |
|---|---|---|
Market Cap | $30.93B | $2.13B |
Volume | 5,033,451 | 57,212,015 |
Sector | Health | Leveraged / Inverse |
52-Week High | $88.16 | $89.43 |
52-Week Low | $59.48 | $31.83 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SQQQ, the ProShares UltraPro Short QQQ ETF, trades at $33.98, up 1.04% today. The technical outlook is bearish, with moving averages signaling a downtrend and oscillators neutral. As a 3x leveraged inverse ETF, it aims to deliver triple the daily inverse performance of the Nasdaq-100 Index. Recent news highlights its use as a hedging tool against tech sector declines, with articles noting potential benefits if the AI-fueled tech rally weakens.
The outlook for SQQQ is inherently tied to Nasdaq-100 volatility; it offers strategic hedging opportunities during market downturns but carries high risk due to leverage decay and daily rebalancing. Investors face significant loss potential if the tech rally persists, requiring careful risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
